Bacterin International Holdings, Inc. (BONE)
-NYSE MKT 0.78 
0.04(5.39%) 4:00PM EDT
| Prev Close: | 0.74 |
|---|
| Open: | 0.74 |
|---|
| Bid: | 0.30 x 100 |
|---|
| Ask: | 0.97 x 200 |
|---|
| 1y Target Est: | 5.00 |
|---|
| Beta: | 2.23 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 0.72 - 0.78 |
|---|
| 52wk Range: | 0.51 - 2.00 |
|---|
| Volume: | 42,280 |
|---|
| Avg Vol (3m): | 147,261 |
|---|
| Market Cap: | 33.51M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.20 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- BACTERIN INTERNATIONAL HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial StateEDGAR Online(Wed 9:37AM EDT)
- BACTERIN INTERNATIONAL HOLDINGS, INC. FinancialsEDGAR Online Financials(Fri, May 17)
- Bacterin Receives Compliance Notice from NYSE MKTBusiness Wire(Thu, May 16)
- BACTERIN INTERNATIONAL HOLDINGS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued ListiEDGAR Online(Thu, May 16)
- Bacterin International Holdings' Management Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Fri, May 10)
- BACTERIN INTERNATIONAL HOLDINGS, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online(Fri, May 10)
- Bacterin Announces First Quarter 2013 Revenue of $8.6 MillionBusiness Wire(Thu, May 9)
- BACTERIN INTERNATIONAL HOLDINGS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial StEDGAR Online(Thu, May 9)
- Q1 2013 Bacterin International Holdings Inc Earnings Release - After Market CloseCCBN(Thu, May 9)
- Bacterin Announces Earnings Release and Conference Call Date for 2013 First Quarter ResultsBusiness Wire(Tue, Apr 30)
- BACTERIN INTERNATIONAL HOLDINGS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online(Tue, Apr 30)
- Rawleigh Hazen Ralls reports 5.2% passive stake in Bacterin Internationalat theflyonthewall.com(Fri, Apr 26)
- Bacterin Announces Selection of Executive Search FirmBusiness Wire(Fri, Apr 26)
- BACTERIN INTERNATIONAL HOLDINGS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online(Fri, Apr 26)
- Bacterin Announces Updates on Executive Leadership Transition PlansBusiness Wire(Wed, Apr 17)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 0.94 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.14 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.03 |
|---|
| Mean Recommendation*: | 1.8 |
|---|
| PEG Ratio (5 yr expected): | -0.29 |
|---|
Business Summary
Bacterin International Holdings, Inc. develops, manufactures, and markets biologics products in the United States and internationally. The companys products are used in various applications, including enhancing fusion in spine surgery, relie...
View More